Explore 3 Stock Ideas & Industry Insights Download Free Report

small-cap

Momentum Model Portfolio Rebalancing: EXIT (ASX: DRO) and ENTRY (ASX: BRN)

Jun 04, 2025 | Team Kalkine
Momentum Model Portfolio Rebalancing:  EXIT (ASX: DRO) and ENTRY (ASX: BRN)
Image source: shutterstock

  • DRO:ASX
  • Investment Type
    Small-Cap
  • Risk Level
  • Action
  • Rec. Price (AU$)
  • BRN:ASX
  • Investment Type
    Small-Cap
  • Risk Level
  • Action
  • Rec. Price (AU$)

Exit Case: DroneShield Limited (ASX: DRO)

Overview: DroneShield Limited (ASX: DRO) is an Australian-based defence technology company that specializes in counter-drone and electronic warfare solutions. The company develops advanced hardware and software systems designed to detect, track, and neutralize unmanned aerial systems (UAS), protecting critical infrastructure, military operations, and civilian spaces from emerging drone threats. DRO has been a part of the 'Momentum Model Portfolio' since 30 April 2025. Therefore, an 'Exit' stance from the Momentum Model Portfolio is recommended on the stock at the current market price of AUD 1.60 as on June 04, 2025, at 10:30 AM AEST.

DRO’s Daily Chart

New Entry Case: BrainChip Holdings Ltd (ASX: BRN)

Overview: BrainChip Holdings Ltd (ASX: BRN) is the world’s first commercial producer of neuromorphic artificial intelligence (AI) intellectual property, pioneering advancements in edge AI. The company specializes in on-chip processing and learning, enabling ultra-low power, real-time AI capabilities directly on edge devices—without reliance on cloud infrastructure.

Technical Analysis: On the daily chart, BRN is trading above a rising trendline support zone, suggesting the potential for further upward movement. Additionally, the 14-period Relative Strength Index (RSI) is rebounding from lower levels and currently reads around 48.92, indicating strengthening momentum. However, the stock is also trading below the 21-period Simple Moving Average (SMA), a trend-following indicator.

BRN is recommended as a new entry in the 'Momentum Model Portfolio' as on June 04, 2025. Considering the technical analysis, support and resistance levels, an 'Entry' is recommended in the 'Momentum Model Portfolio' at the current market price of AUD 0.220 as on June 04, 2025, at 10:30 AM AEST.

BRN’s Daily Chart

Support and Resistance Summary (As on June 04, 2025)

Note 1: Past performance is neither an Indicator nor a guarantee of future performance.

Note 2: The reference date for all price data, and currency as of June 04, 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings.

Disclaimer

This information should not be relied upon as personal financial advice by Kalkine on (i) the stocks or (ii) the use or suitability of the model portfolios. Only an investor knows about their circumstances to make an investment decision.

Model Portfolio has been prepared for illustrative purpose only and does not take into account the objectives, financial situation or needs of any particular investor. Accordingly, investors should, before acting on the information, consider its appropriateness, having regard to their objectives, financial situation and needs. Past performance is not necessarily indicative of future performance results. Actual investment returns will vary, and the value of investments can go up or down.


Disclaimer-

Disclaimer This report has been issued by Kalkine New Zealand Limited (FSP691351) (NZBN:9429047678101) (“Kalkine”). Kalkine is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity securities, managed funds and other managed investment schemes and other financial advice products. The recommendations and opinions in this report and on Kalkine website do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine). Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website. Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.

Past performance is not a reliable indicator of future performance.